Jack Yongfeng Zhang
2014
In 2014, Jack Yongfeng Zhang earned a total compensation of $5M as Chief Executive Officer, Chief Scientific Officer and Director at Amphastar Pharmaceuticals, a 28% increase compared to previous year.
Compensation breakdown
| Bonus | $515,154 |
|---|---|
| Option Awards | $1,225,000 |
| Salary | $882,693 |
| Stock Awards | $2,275,000 |
| Other | $57,191 |
| Total | $4,955,038 |
Zhang received $2.3M in stock awards, accounting for 46% of the total pay in 2014.
Zhang also received $515.2K in bonus, $1.2M in option awards, $882.7K in salary and $57.2K in other compensation.
Rankings
In 2014, Jack Yongfeng Zhang's compensation ranked 1,580th out of 13,032 executives tracked by ExecPay. In other words, Zhang earned more than 87.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,580 out of 13,032 | 88th |
Division Manufacturing | 565 out of 4,965 | 89th |
Major group Chemicals And Allied Products | 179 out of 1,690 | 89th |
Industry group Drugs | 139 out of 1,369 | 90th |
Industry Pharmaceutical Preparations | 119 out of 1,042 | 89th |
Source: SEC filing on April 22, 2016.
Zhang's colleagues
We found two more compensation records of executives who worked with Jack Yongfeng Zhang at Amphastar Pharmaceuticals in 2014.
News
Amphastar Pharmaceuticals CEO Jack Zhang's 2021 pay rises 9% to $6.5M
April 14, 2022
Amphastar Pharmaceuticals General Counsel Jason Shandell's 2020 pay jumps 132% to $6.8M
April 14, 2021
Amphastar Pharmaceuticals CEO Jack Zhang's 2019 pay rises 2% to $6M
April 15, 2020
Amphastar Pharmaceuticals CEO Jack Zhang's 2018 pay rises 2% to $5.9M
April 18, 2019